Feinman Marcie, Cotton Bryan A, Haut Elliott R
aDepartment of Surgery, Johns Hopkins Medicine, Baltimore, Maryland bDepartment of Surgery and The Center for Translational Injury Research, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Curr Opin Crit Care. 2014 Aug;20(4):366-72. doi: 10.1097/MCC.0000000000000104.
This review article explores the recent literature regarding the optimal type and amount of intravenous fluids for the trauma patient from the time of injury through their ICU stay. It discusses damage control principles as well as targeted resuscitation utilizing new technology.
In the prehospital arena, intravenous fluids have been associated with worse patient outcomes due to increased coagulopathy and time to definitive care. Once in the trauma bay, damage control resuscitation principles apply to the severely injured patient. Large volume crystalloid infusion increases mortality. The best patient outcomes have been found with transfusion of blood products in a ratio that closely mimics whole blood. Thrombelastography is a useful adjunct in resuscitation and can help guide the judicious use of blood products. New technology can help providers ascertain when a patient is appropriately resuscitated by determining adequate global and regional perfusion.
During the resuscitation of the acutely injured patient, crystalloids should be limited in favor of blood components. Damage control principles apply until definitive hemostasis is obtained, at which point the focus should change to targeted resuscitation using traditional global endpoints of resuscitation in conjunction with determinants of regional perfusion.
本文探讨了近期关于创伤患者从受伤到入住重症监护病房(ICU)期间静脉输液的最佳类型和剂量的文献。文中讨论了损伤控制原则以及利用新技术进行目标导向复苏的相关内容。
在院前阶段,静脉输液因导致凝血功能障碍加重和确定性治疗时间延长,与患者预后较差相关。一旦进入创伤室,损伤控制复苏原则适用于重伤患者。大量输注晶体液会增加死亡率。按接近全血的比例输注血液制品能取得最佳的患者预后。血栓弹力图是复苏中的有用辅助手段,有助于指导合理使用血液制品。新技术可帮助医护人员通过确定足够的全身和局部灌注情况,来判断患者何时得到了恰当的复苏。
在急性受伤患者的复苏过程中,应限制晶体液的使用,优先选择血液成分。在获得确定性止血之前,应遵循损伤控制原则,此时应将重点转向使用传统的全身复苏终点指标以及局部灌注决定因素进行目标导向复苏。